-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Spinal cord injury is a type of severe central nervous system injury that results in partial or complete loss of sensory and motor functions below the injury level
The Dai Jianwu regenerative medicine research team of the Institute of Genetics and Developmental Biology of the Chinese Academy of Sciences has been committed to the research and clinical transformation of spinal cord regeneration and repair
Recently, Dai Jianwu’s regenerative medicine research team and the clinical hospital cooperation team published a research paper titled " Long-term clinical observation of acute and chronic complete spinal cord injury patients after transplantation of NeuroRegen scaffold " in Science China Life Sciences , and completed 15 The long-term follow-up of 2-5 years of patients with acute complete spinal cord injury and 51 patients with old complete spinal cord injury showed that nerve regeneration collagen scaffold transplantation is safe for the treatment of acute and old complete spinal cord injury and showed preliminary effectiveness.
For patients with spinal cord injury, ASI A is
For old complete spinal cord injury, the scar tissue at the injury site severely hinders nerve regeneration and nerve function recovery
Researcher Dai Jianwu of the Institute of Genetics and Development, Professor Zhang Sai of the Armed Police Medical Characteristics Research Center, and Professor Hou Shuxun of the Fourth Medical Center of the PLA General Hospital are the co-corresponding authors of the article